-
Mashup Score: 1
Dr. Grady discusses ECLIPSE for colorectal cancer screening and the findings that led to approval of the Shield test.
Source: docwirenews.comCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 0
In a study overseen by Christian Jobin, PhD, UF College of Medicine, campylobacter bacteria have been found to be enriched in primary CRC lesions of patients with metastasis.
Source: docwirenews.comCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 1Enhancing low-dose radiotherapy efficacy with PARP inhibitors via FBL-mediated oxidative stress response in colorectal cancer - 1 month(s) ago
Oncogene – Enhancing low-dose radiotherapy efficacy with PARP inhibitors via FBL-mediated oxidative stress response in colorectal cancer
Source: www.nature.comCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 41
Cancer-associated fibroblasts (CAFs) are an abundant component of the tumor microenvironment and have been shown to possess critical functions in tumor progression. Although their roles predominantly have been described as tumor-promoting, more recent findings have identified subsets of CAFs with tumor-restraining functions. Accumulating evidence underscores large heterogeneity in fibroblast subsets in which distinct subsets differentially impact the initiation, progression, and metastasis of colorectal cancer.
Source: www.cmghjournal.orgCategories: General Medicine News, GastroenterologyTweet
-
Mashup Score: 1The role of colorectal cancer plasticity in metastasis and treatment: an interview with Mirjana Efremova - 11 month(s) ago
Mirjana Efremova speaks about her research into how colorectal cells adapt and change through plasticity.
Source: www.oncology-central.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0
Background Early detection has proven to be the most effective strategy to reduce the incidence and mortality of colorectal cancer (CRC). Nevertheless, most current screening programs suffer from low participation rates. A blood test may improve both the adherence to screening and the selection to colonoscopy. In this study, we conducted a serum-based discovery and validation of cfDNA methylation biomarkers for CRC screening in a multicenter cohort of 433 serum samples including healthy controls, benign pathologies, advanced adenomas (AA), and CRC. Results First, we performed an epigenome-wide methylation analysis with the MethylationEPIC array using a sample pooling approach, followed by a robust prioritization of candidate biomarkers for the detection of advanced neoplasia (AN: AA and CRC). Then, candidate biomarkers were validated by pyrosequencing in independent individual cfDNA samples. We report GALNT9, UPF3A, WARS, and LDB2 as new noninvasive biomarkers for the early detection o
Categories: Future of Medicine, Latest HeadlinesTweet-
Glad to have participated in #colorectal #cancer #CRC screening study using DNA #methylation biomarkers in cell-free DNA #cfDNA of more than 400 samples; article published in Clinical Epigenetics @BioMedCentral led by Loretta De Chiara @cinbio_uvigo @uvigo https://t.co/CqBTwWmd6w https://t.co/NY9gyydutH
-
-
Mashup Score: 3GPR37 promotes colorectal cancer liver metastases by enhancing the glycolysis and histone lactylation via Hippo pathway - 1 year(s) ago
Oncogene – GPR37 promotes colorectal cancer liver metastases by enhancing the glycolysis and histone lactylation via Hippo pathway
Source: www.nature.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Oncology Management journal highlights: summer edition - 1 year(s) ago
Read the latest post covering the editors’ highlights of the best reads within in the Oncology Management journals from the past quarter
Source: www.oncology-central.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Cesare Hassan on Using AI for Detecting Colorectal Polyps - 1 year(s) ago
There’s a growing need for cost-saving strategies that allow for optically diagnosing colorectal polyps in order to reduce the patient, economic, and environmental burden of polypectomy and pathology. One recommendation has been to adopt a leave-in-situ approach for small, non-threatening rectosigmoid hyperplastic polyps ≤5 mm and a resect-and-discard approach for more proximal lesions ≤5 mm.
Source: www.medpagetoday.comCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 4SurgOnc Today® - 1 year(s) ago
SurgOnc Today® is an educational podcast for cancer surgeons from the Society of Surgical Oncology. Each episode features conversations with individuals who are experts within their respective fields and are members of SSO. Listen to the most recent episodes below or find all of the SurgOnc Today® episodes, organized by disease site, on ExpertEd@SSO and in the … SurgOnc Today® Read More »
Source: www.surgonc.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
📣 Contemplating a career as a surgical oncologist? Then this episode of SurgOnc Today® is for you! 🎙️ @adwilliams5, @DrZacharyJBrown & @globalsurgallie discuss #surgicaloncology career options, including #breast, #hepatobiliary & #colorectal Listen now: https://t.co/ehFdXjMlcT https://t.co/fSx7Q9Zl1U
-
🔎 Dr. William Grady of @fredhutch shares an overview of the ECLIPSE study and its significance in #colorectal cancer screening, including the FDA approval of the Shield test. 📺 Learn how the Shield test differs from existing CRC screening methods: https://t.co/KL7YFfJMAd https://t.co/Gpn5dNbr0r